{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67105af848726944170ab1fe/6a318d76780d0f7579c4e392?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Philippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders","description":"<p>Philippe Pouletty, MD, is one of Europe’s most successful life sciences entrepreneurs, having spent more than 30 years building category-leading biotechnology and medical technology companies from breakthrough scientific innovations. His most notable achievement is Abivax, which he founded and chaired for a decade, transforming it into a global biotechnology leader that reached an approximately $10 billion market capitalization following positive Phase 3 results in 2025. Today, he is applying the same proven strategy to Carvolix, combining breakthrough implants, AI-powered software, and autonomous mini-robotics to create a next-generation cardiovascular MedTech company focused on improving outcomes for patients with heart valve disease and stroke.</p><p><br></p><p>Produced and hosted by Jonathan D. Grinstein, PhD</p><p>Audio mixed and mastered by Erick Ziegler</p><p>Brought to you by Inside Precision Medicine (SAGE Publishing)</p>","author_name":"Inside Precision Medicine"}